Company intelligence / Profile preview

OMX Ventures

Lincolnshire, IL, United Statesomx.vc ↗

Ownership: Private
Employees: ~9
Development stage: Other

Overview

OMX Ventures is a U.S.-based venture capital firm specializing in early-stage investments at the intersection of biology, big data, and AI. It focuses on building scalable biotech and life sciences startups developing therapeutics, biotechnological tools/instruments, diagnostics platforms, and synthetic biology solutions. The fund supports founders with hands-on guidance in IP strategy and company building. Its first fund closed at $150 million in committed capital in early-stage rounds.

Modalities: Small moleculeMonoclonal antibodyMicrobiome-based therapyGene therapyCRISPR-based therapyPeptidesSynthetic biology platforms/tools
Industry: Investors

Beyond the preview

Go deeper on OMX Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OMX Ventures.

Explore the full profile